Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Jul 15, 2023

The Robot Rally is in Full Swing: Rapid Growth on the Horizon. BNGO Generates Over 3% Profit in Just One Week!

The Robot Rally is in Full Swing: Rapid Growth on the Horizon. BNGO Generates Over 3% Quick Profit with 2 Robots at Once. Swing-Trader-High-Volatility-Stocks-for-Active-Trading-TA-FA https://Swing-trader-Volatility-Balanced-Strategy-v-2-TA And that's just the tip of the iceberg. This week, all the robots combined have earned over 4%, surpassing all possible indices. These robots are designed for traders seeking high-volatility stocks while minimizing drawdowns during downtrends. Our AI robots utilize a range of technical indicators to identify reversal points in uptrends, allowing for balanced short and long positions to prevent significant drawdowns.

These robots are ideal for active traders capable of monitoring 40-50 trades simultaneously. With an average trade duration of one day, users can effectively utilize their capital without being tied up in prolonged trades.

To select stocks, our robots employ a proprietary method developed by our team of quants, evaluating the strength and quality of momentum in the most active stocks in the US market. A sophisticated algorithm, incorporating a pool of technical indicators processed through neural networks, determines entry points for positions.

Once a trade is initiated, our AI robots place a fixed "Take Profit" order at 3.5% of the position's opening price. For exiting a position, the robots utilize two options: a fixed stop loss at 3% of the opening price and a flexible trailing stop, helping preserve most of the profits if the market reverses. Subscribe to our robots and enjoy swift profitability.

Related Ticker: BNGO

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


BNGO saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for BNGO moved out of overbought territory on September 04, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 43 similar instances where the indicator exited the overbought zone. In of the 43 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BNGO broke above its upper Bollinger Band on September 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 31, 2026. You may want to consider a long position or call options on BNGO as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BNGO just turned positive on August 06, 2026. Looking at past instances where BNGO's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

BNGO moved above its 50-day moving average on August 07, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BNGO crossed bullishly above the 50-day moving average on August 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BNGO advanced for three days, in of 214 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 67 cases where BNGO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.449) is normal, around the industry mean (5.056). P/E Ratio (0.002) is within average values for comparable stocks, (144.182). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.254). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (0.381) is also within normal values, averaging (89.729).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BNGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 8.56B. The market cap for tickers in the group ranges from 126 to 129.55B. ISRG holds the highest valuation in this group at 129.55B. The lowest valued company is HGYMF at 126.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -1%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 11%. PDEX experienced the highest price growth at 17%, while NNNN experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 8%. For the same stocks of the Industry, the average monthly volume growth was -47% and the average quarterly volume growth was 10%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 59
Price Growth Rating: 52
SMR Rating: 82
Profit Risk Rating: 95
Seasonality Score: -50 (-100 ... +100)
View a ticker or compare two or three
BNGO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of technologies for analysis of large biological molecules

Industry PharmaceuticalsOther

Profile
Details
Industry
Biotechnology
Address
9540 Towne Centre Drive
Phone
+1 858 888-7600
Employees
97
Web
https://www.bionano.com
Interact to see
Advertisement
Shares of Citigroup (C) declined approximately 5.17% in the most recent completed trading session, closing at $110.19 versus a prior close of $116.19. The primary catalyst was hotter-than-expected U.S. Producer Price Index (PPI) data, stoking fears of persistent inflation and a reduced likelihood of near-term Federal Reserve rate cuts.
AVAV surged +16.83% in Monday's session, trading at $294.70 compared to Friday's closing price of $252.25 — a gain of $42.45 per share. The primary catalyst was a powerful confluence of geopolitical demand and corporate developments: the escalating U.S.-Iran military conflict dramatically amplified investor focus on AeroVironment's loitering munitions portfolio.
Shares of Venture Global surged approximately +16.61% on March 2, 2026, closing at $11.30 compared to the prior close of $9.69. The primary catalyst was a stronger-than-expected Q4 2025 earnings report, with GAAP EPS of $0.41 beating the consensus estimate of $0.36 by $0.05.
Shares of CCL plunged 10.11% in Monday's session, falling from a prior close of $31.55 to $28.36. The primary catalyst was a coordinated U.S. and Israeli military strike on Iran over the weekend, causing crude oil prices to surge approximately 8–9% and triggering a global risk-off selloff.
ADT shares dropped sharply — falling as much as 13.4% intraday and hitting a new 52-week low of $6.65 — after reporting Q4 2025 results before the Monday open. Fourth-quarter revenue and guidance both missed analyst expectations, overshadowing an earnings-per-share beat.
Shares of Karman Holdings surged approximately +13.00% in Monday's session, closing near $99.57, up from a prior close of $88.11. The primary catalyst was the release of the company's fourth-quarter and full-year 2025 financial results, which showed strong revenue growth and exceeded top-line expectations.
Netflix dropped out of a months‑long bidding war for Warner Bros Discovery after Paramount/Skydance raised their offer, and Netflix refused to match it, saying the new price was “no longer financially appealing.” The stock jumped roughly 10%+ on the news as investors read this as fiscal discipline—management chose not to overpay, which protects the balance sheet and future returns instead of chasing scale at any price.
SE shares plunged approximately 23% at Tuesday's open, marking one of the steepest single-session selloffs in recent company history. The primary catalyst was a severe Q4 2025 earnings miss: adjusted EPS of $0.63 fell well short of the analyst consensus of $0.80, a miss of roughly 21%.
Shares of Southern Copper Corporation (SCCO) are down 10.32% in Tuesday's session, trading at $196.27 versus the prior close of $218.85 — a single-day loss of $22.58 per share. The primary catalyst is a Bank of America downgrade issued on March 2, cutting SCCO from Neutral to Underperform, which triggered accelerating sell pressure into Tuesday's open.
MDB shares plummeted approximately 26.44% on March 3, 2026, closing around $238.24, down from a prior close of approximately $322.55. The primary catalyst was weaker-than-expected fiscal Q1 2027 guidance, with non-GAAP EPS projected at $1.15–$1.19 versus analyst expectations of roughly $1.46.
Shares of Battalion Oil Corporation (BATL) are surging approximately +130% in Tuesday's session, with the stock hitting a fresh 52-week high as of intraday trading on March 3, 2026. The dominant catalyst is a sharp escalation of U.S.-Israel-Iran military tensions, with Tehran restricting access to the Strait of Hormuz — triggering a spike in crude oil futures and a broad-based energy sector rally.
Shares of CRDO dropped 18.55% on March 3, 2026, falling from a prior close of $114.22 to approximately $93.03. The primary catalyst was a "sell the news" reaction to fiscal Q3 2026 earnings — despite beating consensus estimates on both revenue and EPS, the market sold off on forward margin compression guidance.
PSIX shares plummeted approximately 25.37% on March 3, 2026, closing near $64.00 versus the prior session's close of $85.75. The primary catalyst was the company's Q4 and full-year 2025 earnings report, which revealed Q4 net income fell 31% year-over-year to $16.1 million despite a 33% revenue increase.
Life360 Inc Common (LIF) stunned many traders today as the stock slid more than 20% despite reporting what, on the surface, looked like very strong results: revenue up roughly 32% year over year to about $489.5 million and the company’s first-ever full‑year profitability.
StoneCo Ltd. (STNE) shares dropped more than 15% today after the market reacted negatively to the company’s latest Q4 2025 and full‑year results and its updated outlook. While StoneCo delivered year‑over‑year revenue and earnings growth and even topped EPS expectations, investors focused on weaker‑than‑hoped revenue numbers, rising credit risk metrics, and a more cautious medium‑term guidance profile, which together triggered a sharp rerating of the stock.
Alamo Group reported Q4 2025 EPS of about 1.70 dollars, well below analyst expectations that were in the low‑2 dollar range, producing a sizable negative earnings surprise. Quarterly revenue came in around 373.7 million dollars, down roughly 3% year over year and about 7–8% below consensus estimates near 405 million dollars, signaling softer demand than the market anticipated.
Hycroft Mining Holding Corp (HYMC) shares slid more than 12% today as traders digested the company’s newly filed 2025 annual report, a major corporate update, and an extended development timeline that shifts the story further away from near‑term production and cash flow.
PicS (PICS) shares dropped more than 12% today as investors reacted to mounting concerns about valuation, elevated volatility, and uncertainty ahead of the company’s next earnings report later in March.
Shares of MOBX surged approximately +532.77% in the March 3, 2026 trading session, closing at $1.12 versus a prior close of $0.18. The primary catalyst was a major production purchase order from the U.S. Navy for components used in the Tomahawk cruise missile program.
DAKT shares are declining approximately -10% in Wednesday's session, trading near $23.91, compared to the prior close of approximately $26.57. The primary catalyst is the pre-market release of fiscal Q3 2026 earnings, in which diluted EPS of $0.06 fell significantly short of the consensus estimate of approximately $0.13–$0.15.